← Leaderboards
Wolfgang Christoph Winkelmayer
Baylor College Of Medicine
$6,066,937
Attributed
$6,066,937
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $927.3K · FY2009–23$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,066,937 · 4
By mechanism
R01$5,590,687 · 2
R21$466,250 · 1
R13$10,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Steven A Abrams$3,766,448
- Joseph N Chorley$35,952
- Mark M Udden$4,564
- Robert A Britton$17,520,348
Others in their field
Top investigators on “Interest”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Everette D Joseph · Howard University$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- David Heimbrook · Leidos Biomedical Research, Inc.$231,553,599
- Clare E Reimers · Gordon Research Conferences$206,081,841
Research focus
InterestDialysis ProcedureCardiovascular SystemEnd Stage Renal FailureFundingKidney DiseasesMedicarePatient PopulationAmericanKidneyCessation Of LifePharmaceutical PreparationsHemoglobinStrokeDiagnosisEventDatabasesProviderOlder PatientAtrial FibrillationRenal DialysisPatternLaboratoriesDiabetes Mellitus
Grant awards (15)
The Atrial Fibrillation-Factor Identification to Risk Modification Study in CKD/ESRD$515,582
R01 · FY2023 · DK · contact PI
The Atrial Fibrillation-Factor Identification to Risk Modification Study in CKD/ESRD$525,282
R01 · FY2022 · DK · contact PI
The Atrial Fibrillation-Factor Identification to Risk Modification Study in CKD/ESRD$688,545
R01 · FY2021 · DK · contact PI
The Atrial Fibrillation-Factor Identification to Risk Modification Study in CKD/ESRD$648,717
R01 · FY2020 · DK · contact PI
The Atrial Fibrillation - Factor Identification to Risk Modification Study in HD$450,515
R01 · FY2015 · DK · contact PI
The Atrial Fibrillation - Factor Identification to Risk Modification Study in HD$465,609
R01 · FY2014 · DK · contact PI
The Atrial Fibrillation - Factor Identification to Risk Modification Study in HD$462,674
R01 · FY2013 · DK · contact PI
Comparative Effectiveness and Safety of Newer Agents for Anemia Treatment in HD$331,645
R01 · FY2013 · DK · contact PI
Comparative Effectiveness and Safety of Newer Agents for Anemia Treatment in HD$82,919
R01 · FY2013 · DK · contact PI
The Atrial Fibrillation - Factor Identification to Risk Modification Study in HD$504,227
R01 · FY2012 · DK · contact PI
Comparative Effectiveness and Safety of Newer Agents for Anemia Treatment in HD$413,071
R01 · FY2012 · DK · contact PI
2012 ASN Update on Patient Centered Outcomes Research in Kidney Disease$10,000
R13 · FY2012 · DK · contact PI
Comparative Effectiveness and Safety of Newer Agents for Anemia Treatment in HD$501,901
R01 · FY2011 · DK · contact PI
Warfarin Use in ESRD Patients with Atrial Fibrillation: Risks, Benefits, Behavior$200,000
R21 · FY2010 · DK · contact PI
Warfarin Use in ESRD Patients with Atrial Fibrillation: Risks, Benefits, Behavior$266,250
R21 · FY2009 · DK · contact PI